Exemestane in Advanced and Recurrent Endometrial Carcinoma

NCT01965080 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

52

Enrollment

OTHER

Sponsor class

Conditions

Endometrial Cancer

Interventions

DRUG: Exemestane

Sponsor

Nordic Society of Gynaecological Oncology - Clinical Trials Unit